We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
-$3.14B
Cap. Flow
-$4.13B
Cap. Flow %
-28.38%
Top 10 Hldgs %
20.74%
Holding
1,655
New
313
Increased
216
Reduced
349
Closed
770

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$214M
2
MDT icon
Medtronic
MDT
+$123M
3
CHTR icon
Charter Communications
CHTR
+$97.9M
4
MRK icon
Merck
MRK
+$94M
5
ZTS icon
Zoetis
ZTS
+$91.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$253M
2
BIDU icon
Baidu
BIDU
+$120M
3
STZ icon
Constellation Brands
STZ
+$110M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$104M
5
ABT icon
Abbott
ABT
+$98.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.1%
2 Technology 16.39%
3 Industrials 11.22%
4 Consumer Discretionary 9.86%
5 Financials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLW icon
976
Clearwater Paper
CLW
$376M
– –
-17,260
Closed -$399K
CMC icon
977
Commercial Metals
CMC
$8.31B
– –
-61,437
Closed -$1.3M
CMG icon
978
Chipotle Mexican Grill
CMG
$41.5B
– –
-343,450
Closed -$2.96M
CMRE icon
979
Costamare
CMRE
$1.77B
– –
-12,349
Closed -$99K
CNMD icon
980
CONMED
CNMD
$1.47B
– –
-44,536
Closed -$3.26M
COLB icon
981
Columbia Banking Systems
COLB
$8.84B
– –
-28,468
Closed -$1.16M
COLL icon
982
Collegium Pharmaceutical
COLL
$956M
– –
-14,447
Closed -$345K
VISN
983
Vistance Networks Inc
VISN
$2.52B
– –
-2,558,683
Closed -$74.7M
CORT icon
984
Corcept Therapeutics
CORT
$12B
– –
-65,012
Closed -$1.02M
CPRX
985
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-105,345
Closed -$329K
CRAI icon
986
CRA International
CRAI
$1.06B
– –
-16,506
Closed -$840K
CRESY
987
Cresud
CRESY
$773M
– –
-90,533
Closed -$1.2M
CRH icon
988
CRH
CRH
$66.8B
– –
-139,703
Closed -$4.94M
CRIS icon
989
Curis
CRIS
$7.83M
– –
-75
Closed -$52K
CRI icon
990
Carter's
CRI
$1.47B
– –
-46,588
Closed -$5.05M
CRL icon
991
Charles River Laboratories
CRL
$12.8B
– –
-57,307
Closed -$6.43M
CRMT icon
992
America's Car Mart
CRMT
$26.9M
– –
-24,654
Closed -$1.53M
CROX icon
993
Crocs
CROX
$6.55B
– –
-562,762
Closed -$9.91M
CSR
994
Centerspace
CSR
$952M
– –
-12,125
Closed -$671K
CTLP
995
DELISTED
Cantaloupe
CTLP
– –
-215,721
Closed -$3.02M
CTRE icon
996
CareTrust REIT
CTRE
$9.74B
– –
-259,906
Closed -$4.34M
CTRA
997
DELISTED
Coterra Energy
CTRA
– –
-73,375
Closed -$1.75M
CUK
998
DELISTED
Carnival PLC
CUK
– –
-54,977
Closed -$3.17M
CVBF icon
999
CVB Financial
CVBF
$3.99B
– –
-26,884
Closed -$603K
CVCO icon
1000
Cavco Industries
CVCO
$4.55B
– –
-4,333
Closed -$900K
38 39
40
41 42

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace North America held 1,655 positions worth $14.6B, down 18% from $17.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Marshall Wace North America withdrew a net $4.13B in Q3 2018, closing 770 positions and reducing 349 holdings. Its most notable exit was Baidu, an estimated $120M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Marshall Wace North America opened a new position in Medtronic worth $130M.

  • Marshall Wace North America's largest Q3 2018 buy was Medtronic: 1,325,878 shares worth $130M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q3 2018, an estimated $214M increase.
  • Marshall Wace North America's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $253M.
  • Marshall Wace North America fully exited Baidu in Q3 2018, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 21% of its $14.6B portfolio in Q3 2018.
  • Marshall Wace North America opened 313 new positions and closed 770 in Q3 2018.
  • Marshall Wace North America's portfolio value fell 18% quarter-over-quarter to $14.6B.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.